December 2022

Key FDA updates you may have missed | An expert's thoughts on TAVR valve durability | Coffee & severe hypertension ()
December's Most Popular Stories: Heart valve specialist wins Survivor | Key recalls | Malpractice claims | Much more! ()
A new recall | Adjustable stents for children | No antithrombotic therapy after TAVR? | More from the last week ()
TAVR Highlights: Heart valve specialist wins Survivor | Promising data from Medtronic & Boston Scientific ()
More than 2,000 intra-aortic balloon pumps recalled | Developing the cardiology workforce | Stroke outcomes ()
Heart Rhythm Highlights: COVID linked to another heart condition | Progress for pulsed-field ablation research ()
Cardiac Imaging Highlights: FDA-cleared AI models | New tech making a big impact | Much more ()
News Alert: FDA announces recall of intra-aortic balloon pumps due to risk of cardiac arrest, stroke or death ()
How cardiologists can fight back against misinformation | AI specialists ink deal with Pfizer ()
Top video content in 2022 ()
Care Delivery Highlights: Supply chain problems continue to hit cardiology | Surgeons make history ()
No antithrombotic therapy after TAVR? | Reducing the risk of heart damage among cancer patients ()
New adjustable stents for children | World’s leading cardiology groups say it is time to rethink RCTs ()
Heart valve specialist wins Survivor | Boston Scientific's $523M acquisition | More from the last week ()
Heart valve specialist wins Survivor, donates $1M prize | Cardiologist the subject of several malpractice claims ()
2 key technologies may change cardiovascular medicine | Northwestern outpatient cardiac clinic expands access ()
Heart Health Highlights: Plant-based diets | Former surgeon general's message to cardiologists | Illegal supplements ()
COVID-19 infection & vaccination linked to debilitating heart condition | The No. 1 cause of death in the world ()
Boston Scientific's $523M transaction | How cardiologists can help patients make tough financial decisions ()
Vascular & Endovascular Highlights: The world's most expensive drug | A closer look at the BEST-CLI trial ()
Identifying high-risk PCI patients | RA & Parkinson’s meds linked to cardiovascular benefits ()
Supply chain problems | FDA changes heart pump indications | DASH diet & CVD | More from the last week ()
Heart Failure Highlights: A new recall for troubled device | Surgeons make history | The impact of high copays ()
Alternative therapies for heart failure | Is a device shortage on the way? | FDA clears AI solution for HFpEF ()
Comparing the latest TAVR devices | Interventional cardiology to join the Match in 2025 ()
News Alert: Interventional cardiology to join the Match in 2025 ()
Interventional Cardiology Highlights: RA vs. SV grafts for CABG | Supply chain problems | VR for cardiologists ()
DASH diet reduces long-term risk of heart disease | Oversized LAAO devices | A new wearable heart monitor ()
Economics Highlights: Elon Musk & Eli Lilly | FDA approves world’s most expensive drug | Medicare cuts ()
FDA updates indications for Impella RP | Seaweed & heart surgery? | Progress for pulsed-field ablation trial ()
FDA warns of a shortage of intra-aortic balloon pumps & related parts | Heart device recalled again ()
Transcatheter tricuspid valve replacement | Heart device recalled again | Plant-based diets | More from the last week ()
News Alert: FDA announces another recall for troubled heart device after multiple hospitalizations ()
November's Most Popular Stories: Docs disappointed in CMS | Elon Musk & Eli Lilly | Illegal supplements | Much more! ()
Cardiologist urges physicians to promote plant-based diets | Boston Scientific's new TAVR system ()
Care Delivery Highlights: Cardiac surgeons make history | RA grafts vs. SV grafts for CABG | Telehealth & CVD ()